Literature DB >> 28676901

Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?

Alessandro Sartini1, Stefano Gitto2, Erica Villa3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28676901     DOI： 10.1007/s10620-017-4665-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

1.  Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.

Authors:  Rotonya M Carr; Arpan Patel; Hillary Bownik; Amanke Oranu; Caroline Kerner; Amy Praestgaard; Kimberly A Forde; K Rajender Reddy; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2017-03-06       Impact factor: 3.199

2.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

3.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

Review 4.  Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.

Authors:  Taina Sipponen; Kaija-Leena Kolho
Journal:  Scand J Gastroenterol       Date:  2015-01       Impact factor: 2.423

5.  Management of Crohn's disease in adults.

Authors:  Gary R Lichtenstein; Stephen B Hanauer; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2009-01-06       Impact factor: 10.864

6.  The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases.

Authors:  J R Kramer; J A Davila; E D Miller; P Richardson; T P Giordano; H B El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2007-11-08       Impact factor: 8.171

Review 7.  Glucocorticoids and non-alcoholic fatty liver disease.

Authors:  Conor P Woods; Jonathon M Hazlehurst; Jeremy W Tomlinson
Journal:  J Steroid Biochem Mol Biol       Date:  2015-08-01       Impact factor: 4.292

8.  Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.

Authors:  Talat Bessissow; Ngoc Han Le; Kathleen Rollet; Waqqas Afif; Alain Bitton; Giada Sebastiani
Journal:  Inflamm Bowel Dis       Date:  2016-08       Impact factor: 5.325

9.  Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.

Authors:  Donghee Kim; W Ray Kim; Hwa Jung Kim; Terry M Therneau
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

10.  Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans.

Authors:  Selvi Thirumurthi; Reezwana Chowdhury; Peter Richardson; Neena S Abraham
Journal:  Dig Dis Sci       Date:  2009-12-24       Impact factor: 3.199
View more
  1 in total

Review 1.  Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approach.

Authors:  Mercedes Perez-Carreras; Begoña Casis-Herce; Raquel Rivera; Inmaculada Fernandez; Pilar Martinez-Montiel; Victoria Villena
Journal:  World J Gastroenterol       Date:  2021-11-07       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.